Literature DB >> 17253628

Fluorescence in situ hybridization is necessary to detect an association between chromosome aberrations and polycyclic aromatic hydrocarbon exposure in utero and reveals nonrandom chromosome involvement.

Kirsti A Bocskay1, Manuela A Orjuela, Deliang Tang, Xinhua Liu, Dorothy Warburton, Frederica P Perera.   

Abstract

Chromosome aberrations are associated with environmental exposures in infants and children. Recently we reported that prenatal exposure to airborne polycyclic aromatic hydrocarbons (PAHs) was significantly (P < 0.01) associated with stable aberration frequencies in cord blood from a subset of 60 newborns from the Columbia Center for Children's Environmental Health Prospective Cohort Study (Bocskay K et al. [ 2005]: Cancer Epidemiol Biomarkers Prev 14:506-511). To determine whether the environmental exposures may be targeting specific chromosomes and to compare various methods for measuring chromosome aberrations, we further evaluated this same subset of subjects composed of African-American and Dominican nonsmoking mother-newborn pairs residing in low-income neighborhoods of New York City, and exposed to varying levels of airborne PAHs. Chromosome aberrations were measured in cord blood lymphocytes, both by whole chromosome probe (WCP) fluorescence in situ hybridization (FISH) and traditional Giemsa-staining. Prenatal exposures were assessed by personal air monitoring. Breaks in chromosomes 1-6, as detected by WCP FISH, were nonrandomly distributed, underscoring the importance of appropriate chromosome probe selection to capture cytogenetic damage in response to exposure. FISH for stable aberrations was found to be a more sensitive method for detecting aberration frequencies associated with environmental exposures, when compared with FISH for unstable aberrations or Giemsa-staining for aberrations. Together, these results suggest that PAHs may be targeting specific chromosomes and highlight the importance of using the more sensitive detection methods to assess risk in populations with low levels of exposure. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17253628      PMCID: PMC3232030          DOI: 10.1002/em.20276

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  52 in total

1.  Frequencies of X-ray-induced chromosome translocations in human peripheral lymphocytes as detected by in situ hybridization using chromosome-specific DNA libraries.

Authors:  A T Natarajan; R C Vyas; F Darroudi; S Vermeulen
Journal:  Int J Radiat Biol       Date:  1992-02       Impact factor: 2.694

2.  Chromosome analysis by fluorescence in situ hybridization: further indications for a non-DNA-proportional involvement of single chromosomes in radiation-induced structural aberrations.

Authors:  S Knehr; H Zitzelsberger; H Braselmann; U Nahrstedt; M Bauchinger
Journal:  Int J Radiat Biol       Date:  1996-10       Impact factor: 2.694

3.  A comparison of conventional metaphase analysis of Giemsa-stained chromosomes with multi-colour fluorescence in situ hybridization analysis to detect chromosome aberrations induced by daunomycin.

Authors:  S Ellard; S Toper; G Stemp; E M Parry; P Wilcox; J M Parry
Journal:  Mutagenesis       Date:  1996-11       Impact factor: 3.000

4.  Chromosome aberrations in human lymphocytes analysed by fluorescence in situ hybridization after in vitro irradiation, and in radiation workers, 11 years after an accidental radiation exposure.

Authors:  G Stephan; S Pressl
Journal:  Int J Radiat Biol       Date:  1997-03       Impact factor: 2.694

5.  The effects of age and lifestyle factors on the accumulation of cytogenetic damage as measured by chromosome painting.

Authors:  M J Ramsey; D H Moore; J F Briner; D A Lee; L a Olsen; J R Senft; J D Tucker
Journal:  Mutat Res       Date:  1995-10       Impact factor: 2.433

6.  Validation of chromosome painting as a biodosimeter in human peripheral lymphocytes following acute exposure to ionizing radiation in vitro.

Authors:  J D Tucker; M J Ramsey; D A Lee; J L Minkler
Journal:  Int J Radiat Biol       Date:  1993-07       Impact factor: 2.694

7.  Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion.

Authors:  F E Alexander; S L Patheal; A Biondi; S Brandalise; M E Cabrera; L C Chan; Z Chen; G Cimino; J C Cordoba; L J Gu; H Hussein; E Ishii; A M Kamel; S Labra; I Q Magalhães; S Mizutani; E Petridou; M P de Oliveira; P Yuen; J L Wiemels; M F Greaves
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

8.  Morphologic, immunologic and cytogenetic studies in acute myeloid leukemia following occupational exposure to pesticides and organic solvents.

Authors:  A Cuneo; F Fagioli; I Pazzi; A Tallarico; R Previati; N Piva; M G Carli; M Balboni; G Castoldi
Journal:  Leuk Res       Date:  1992-08       Impact factor: 3.156

9.  Correlation between selected environmental exposures and karyotype in acute myelocytic leukemia.

Authors:  M M Crane; S S Strom; S Halabi; E L Berman; J J Fueger; M R Spitz; M J Keating
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1996-08       Impact factor: 4.254

10.  On the frequency of chromosome exchanges in a control population measured by chromosome painting.

Authors:  J D Tucker; D A Lee; M J Ramsey; J Briner; L Olsen; D H Moore
Journal:  Mutat Res       Date:  1994 Oct-Dec       Impact factor: 2.433

View more
  2 in total

1.  Prenatal PAH exposure is associated with chromosome-specific aberrations in cord blood.

Authors:  Manuela A Orjuela; Xinhua Liu; Dorothy Warburton; Aisha L Siebert; Claudia Cujar; Deliang Tang; Vaidehi Jobanputra; Frederica P Perera
Journal:  Mutat Res       Date:  2010-08-13       Impact factor: 2.433

2.  Urinary naphthol metabolites and chromosomal aberrations in 5-year-old children.

Authors:  Manuela A Orjuela; Xinhua Liu; Rachel L Miller; Dorothy Warburton; Deliang Tang; Vaidehi Jobanputra; Lori Hoepner; Ida Hui Suen; Silvia Diaz-Carreño; Zheng Li; Andreas Sjodin; Frederica P Perera
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-05-09       Impact factor: 4.254

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.